Glaxo Adds Heart Attack Warning To Avandia
The FDA announced Wednesday that Avandia's label would now warn patients that the medication could increase the patients' risk of suffer a heart attack.
“FDA has moved expeditiously to review the cardiovascular risks of this drug so that we could inform patients and doctors at the earliest possible time of our findings,” said...
Already a subscriber? Click here to login